Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ludwig Institute for Cancer Research
Pfizer
National Institutes of Health Clinical Center (CC)
Brown University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Stanford University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Altor BioScience
National Institutes of Health Clinical Center (CC)